Breaking News Instant updates and real-time market news.

AVYA

Avaya

$13.01

-0.28 (-2.11%)

08:09
09/12/19
09/12
08:09
09/12/19
08:09

Avaya provides update on strategic review of alternatives

Avaya provided an update regarding its review of strategic alternatives announced earlier this year. Avaya had previously disclosed its expectation that this process would be concluded by mid-September. Avaya confirmed that its review of a range of strategic alternatives is ongoing and it remains in advanced discussions. Avaya's board of directors and management, supported by its legal and financial advisors, are working to conclude the review. There can be no assurances regarding the timing of any action or transaction nor that the strategic review process will result in any particular outcome. The company does not intend to provide additional updates unless or until it determines that further disclosure is necessary.

AVYA Avaya
$13.01

-0.28 (-2.11%)

03/27/19
BWSF
03/27/19
NO CHANGE
Target $32
BWSF
Strong Buy
Avaya back on investor radars after buyout report, says BWS Financial
A report from Reuters about Avaya (AVYA) possibly being acquired by private equity has put the stock back on investors' radars, BWS Financial analyst Hamed Khorsand tells investors in a research note. He believes the "misunderstanding" of the company's business had "created a significant value gap." The analyst notes, however, that the news report suggests a takeover bid of $20, which is well below his price target of $32. The delta between the reported takeout price and the $32 target is predominately set on how much debt private equity would be willing to put back on Avaya's balance sheet, Khorsand contends. The analyst continues to believe there is "considerable possibility" of Avaya purchasing technology to fill-in its cloud offering. However, that should not prevent a going private bid, says Khorsand. He has a Buy rating on Avaya.
04/09/19
BWSF
04/09/19
NO CHANGE
Target $32
BWSF
Buy
Avaya could fetch up to $25 from PE buyer, says BWS Financial
Additional news reports about Avaya (AVYA) possibly going private since an initial Reuters report build some credibility about the news, said BWS Financial analyst Hamed Khorsand, who believes Avaya could fetch as much as $25 from a private equity buyer using fiscal 2019 estimates and could be worth as much $30 assuming no improvement in the business for fiscal 2020. He thinks greater synergies could be extracted by a strategic buyer and continues to believe Microsoft (MSFT) would be the best fit as an acquirer. Khorsand keeps a Buy rating and $32 price target on Avaya shares.
05/10/19
BWSF
05/10/19
NO CHANGE
Target $22
BWSF
Buy
Avaya price target lowered to $22 from $32 at BWS Financial
BWS Financial analyst Hamed Khorsand lowered his price target for Avaya to $22 from $32 saying the company has an "up-hill challenge of regaining investor confidence" following the weaker than expected fiscal Q2 results. Avaya claimed Reuters' story of the company being approached by a third party caused some customers to hold off on hardware and software licenses at the very end of the quarter. Khorsand, however, said he has "never seen this kind of excuse used before and find it difficult to believe." Nonetheless, given the stock's discount to his new price target, the analyst keeps a Buy rating on Avaya.
08/14/19
MSCO
08/14/19
NO CHANGE
Target $14
MSCO
Equal Weight
Avaya price target lowered to $14 from $18.50 at Morgan Stanley
Morgan Stanley analyst Meta Marshall said Avaya demonstrated some stabilization of results in Q3, but she thinks completion of the company's strategic review represents the best opportunity to achieve her $14 price target, which is down from $18.50 previously, given the continued deterioration of its installed base and ongoing shareholder turnover. The pressure seen on the stock over the past 3 months will continue if Avaya wants to complete its cloud transition on their own, said Marshall, who keeps an Equal Weight rating on Avaya shares.

TODAY'S FREE FLY STORIES

LRCX

Lam Research

$231.75

-3.16 (-1.35%)

15:34
10/23/19
10/23
15:34
10/23/19
15:34
Options
Lam Research options imply 8.3% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 05

    Nov

  • 19

    Nov

  • 20

    Nov

15:31
10/23/19
10/23
15:31
10/23/19
15:31
Conference/Events
Morgan Stanley oil/gas E&P analysts to hold an analyst/industry conference call »

Analysts, along with…

POAI

Predictive Oncology

$0.41

-0.01 (-2.38%)

15:25
10/23/19
10/23
15:25
10/23/19
15:25
Conference/Events
Predictive Oncology to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

MU

Micron

$44.56

-0.12 (-0.27%)

15:23
10/23/19
10/23
15:23
10/23/19
15:23
Recommendations
Micron analyst commentary  »

Micron files annual…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 06

    Nov

  • 20

    Nov

NSC

Norfolk Southern

$184.63

-4.22 (-2.23%)

15:22
10/23/19
10/23
15:22
10/23/19
15:22
Downgrade
Norfolk Southern rating change  »

Norfolk Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

EBAY

eBay

$39.00

0.03 (0.08%)

15:19
10/23/19
10/23
15:19
10/23/19
15:19
Options
EBay options imply 8.7% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 29

    Oct

GOGO

Gogo

$5.99

0.08 (1.35%)

15:18
10/23/19
10/23
15:18
10/23/19
15:18
Hot Stocks
Gogo AVANCE platform exceeds 175,000 business aviation flights »

Gogo Business Aviation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 20

    Nov

FSV

FirstService

$96.64

-8.71 (-8.27%)

15:18
10/23/19
10/23
15:18
10/23/19
15:18
Earnings
FirstService reports Q3 adjusted EPS 92c, consensus $1.03 »

Earlier, FirstService…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
10/23/19
10/23
15:17
10/23/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
10/23/19
10/23
15:16
10/23/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSV

FirstService

$96.64

-8.71 (-8.27%)

15:15
10/23/19
10/23
15:15
10/23/19
15:15
Earnings
Correction: FirstService reports Q3 adjusted EPS 92c, consensus $1.03 »

Earlier, FirstService…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

FSV

FirstService

$96.64

-8.71 (-8.27%)

15:13
10/23/19
10/23
15:13
10/23/19
15:13
Recommendations
FirstService analyst commentary  »

FirstService estimates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

15:12
10/23/19
10/23
15:12
10/23/19
15:12
Conference/Events
Morgan Stanley financial services analysts hold analyst/industry conference call »

Financial Analysts Cyprys…

MSFT

Microsoft

$136.19

-0.2 (-0.15%)

15:07
10/23/19
10/23
15:07
10/23/19
15:07
On The Fly
Fly Intel: What to watch in Microsoft earnings report »

Microsoft (MSFT) is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 26

    Oct

  • 27

    Oct

  • 29

    Oct

  • 06

    Nov

  • 14

    Nov

  • 21

    Nov

XOM

Exxon Mobil

$69.49

0.38 (0.55%)

15:06
10/23/19
10/23
15:06
10/23/19
15:06
Hot Stocks
Qilak LNG executes heads of agreement with ExxonMobil for natural gas »

Qilak LNG, a Lloyds…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

XLNX

Xilinx

$93.83

-2.18 (-2.27%)

15:04
10/23/19
10/23
15:04
10/23/19
15:04
Options
Xilinx options imply 11.9% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 20

    Nov

FTNW

FTE Networks

$1.15

0.28 (32.18%)

14:52
10/23/19
10/23
14:52
10/23/19
14:52
Hot Stocks
Breaking Hot Stocks news story on FTE Networks »

FTE Networks Inc trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$254.68

-0.94 (-0.37%)

14:49
10/23/19
10/23
14:49
10/23/19
14:49
Options
Tesla options imply 11.9% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

KR

Kroger

$24.96

0.1 (0.40%)

14:45
10/23/19
10/23
14:45
10/23/19
14:45
Options
Kroger call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

14:45
10/23/19
10/23
14:45
10/23/19
14:45
General news
Treasury's $41 B 5-year auction was well supported »

Treasury's $41 B…

GSK

GlaxoSmithKline

$43.20

0.69 (1.62%)

, MYGN

Myriad Genetics

$32.14

-0.15 (-0.46%)

14:38
10/23/19
10/23
14:38
10/23/19
14:38
Hot Stocks
FDA approves niraparib for HRD-positive advanced ovarian cancer »

On October 23, the Food…

GSK

GlaxoSmithKline

$43.20

0.69 (1.62%)

MYGN

Myriad Genetics

$32.14

-0.15 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 30

    Oct

  • 06

    Nov

  • 13

    Nov

  • 07

    Dec

TSLA

Tesla

$253.92

-1.7 (-0.67%)

14:27
10/23/19
10/23
14:27
10/23/19
14:27
On The Fly
Fly Intel: What to watch in Tesla earnings report »

Tesla (TSLA) is scheduled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

14:25
10/23/19
10/23
14:25
10/23/19
14:25
Conference/Events
Senate Caucus on International Narcotics Control holds a hearing »

The Caucus holds a…

ALKS

Alkermes

$19.30

0.88 (4.78%)

14:22
10/23/19
10/23
14:22
10/23/19
14:22
Recommendations
Alkermes analyst commentary  »

Alkermes making some…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

TSLA

Tesla

$253.68

-1.94 (-0.76%)

14:22
10/23/19
10/23
14:22
10/23/19
14:22
Periodicals
Tesla sued over Model S door handle malfunction, CCN says »

The family of a man who…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.